Xiangxue pharmaceutical: the controlling shareholder terminates the agreement and transfers the shares of the company
Xiangxue pharmaceutical announced that in view of the changes in the current market environment and the impact of the epidemic situation, the controlling shareholder Kunlun investment and Hengshu No. 1 terminated the agreement to transfer the company's shares. Kunlun investment originally planned to transfer 9.98% of the company's shares to Hengshu No. 1.
This text is a result of machine translation.
Related companies：
In-depth
Technology
ePropulsion: Pioneering Electric Marine Propulsion for a Sustainable Future
EqualOcean recently had an insightful conversation with Mr. Tao Shizheng, the visionary founder of ePropulsion (Chinese: 逸动科技), we embarked on a journey to understand the essence of the company's profound impact on the electric marine propulsion industry.
Jan 25, 2024 02:24 PM
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Briefing Jan 09, 2022 09:29 AM
· Technology
Lenovo tablet shipped more than 11 million units in Wentai technology
Briefing Oct 08, 2021 12:18 PM
· Technology
Insider: it is expected that Delta, a subsidiary of Wentai technology, will resume production as soon as the end of the month
Briefing Sep 22, 2021 07:44 PM
· Technology
The CSRC approved the IPO registration of two companies on the science and innovation board
Briefing Sep 15, 2021 08:44 AM
CITIC Securities: driven by Apple's new computer, the performance growth of the industrial chain company in the third quarter has high certainty
Briefing Sep 05, 2021 11:18 AM
· Technology
In August, the bulk trading of institutional seats decreased slightly, mainly taking over information technology, electronic equipment and chemical stocks
See more
Read next
Insight
In-depth
Insight
In-depth